Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19
COVID-19
Registry Study on the Efficacy of a Self-test and Self-alert Applet in Detecting Susceptible Infection of COVID-19 --a Population Based Mobile Internet Survey
1 other identifier
observational
102,456
1 country
1
Brief Summary
The "COVID-19 infection self-test and alert system" (hereinafter referred to as "COVID-19 self-test applet") jointly developed by Beijing Tsinghua Changgung Hospital, Institute for precision medicine, artificial intelligence of Tsinghua University was launched on February 1,2020. Residents , according to their actual healthy situation, after answering questions online, the system will conduct intelligent analysis, make disease risk assessment and give healthcare and medical guidance. Based on the Internet population survey, and referring to the diagnosis and screening standards of the National Health Commission of the People's Republic of China, investigators carried out the mobile applet of Internet survey and registry study for the Internet accessible identifiable population, so as to screen the suspected population and guide the medical treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2020
CompletedStudy Start
First participant enrolled
February 1, 2020
CompletedFirst Posted
Study publicly available on registry
February 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2020
CompletedJuly 7, 2020
July 1, 2020
5 months
February 1, 2020
July 5, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
positive number diagnosed by national guideline in the evaluated population
after the end of this study, investigators calculate and sum up the total evaluated population and positively diagnosed population, then check the ROC of this system, finally to calculate the sensitivity and accuracy of this self-test and self-alert system
5 months
Secondary Outcomes (3)
distribution map of evaluated people
5 month
Effect of medical guidance by designated feedback questionnaire
5 month
mental scale of relief the mental anxiety and avoid unnecessary outpatient
5 month
Interventions
1\. make a questionnaire, the content of which refers to the new coronavirus diagnosis and treatment guidelines released by the National Health Commission; 2. develop the mobile applet and carry out internet propagation; 3. background data could be identified according to computer technology, de duplication and de privacy; 4. once registered, the applet can automatically remind the self-test twice a day, and encourage to adhere to 14 days; 5. automatically compare with the standards and highly suspected population could be given medical guidance and encouraged to go to the fever clinic of the designated hospital for definite diagnosis.
Eligibility Criteria
Most people including healthy or susceptible patients or diagnosed patients will be enrolled. People whoever worry about his heath status relating with infection of COVID-19 at present can register and answer the question and get a score for risk evaluation. If a high risk achieved, the applet will guide the interviewer for further medical diagnosis and treatment.
You may qualify if:
- people who lived in or out of China at present and threatened by the infection and spread of COVID-19
- without gender and age restriction
- people who have concerns of his health
- voluntary completion of the self-test and evaluation.
You may not qualify if:
- people who are not internet accessible or can not use this Mobile Applet.
- people who can not recognize the questionnaire.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beijing Tsinghua Chang Gung Hospitallead
- Institute for precision medicine of Tsinghua Universitycollaborator
- Institute for artificial intelligent of Tsinghua Universitycollaborator
- Chinese Medical Doctor Associationcollaborator
- Institute for network behavior of Tsinghua Universitycollaborator
- school of clinical medicine of Tsinghua Universitycollaborator
Study Sites (1)
Beijing Tsinghua Changgung Hospital
Beijing, Beijing Municipality, 102218, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jiahong Dong, M.D
Beijing Tsinghua Changgeng Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 1, 2020
First Posted
February 5, 2020
Study Start
February 1, 2020
Primary Completion
July 1, 2020
Study Completion
July 1, 2020
Last Updated
July 7, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share